McKelvey R - Search Results

1

Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.

Stewart JD, McKelvey R, Durcan L, Carpenter S, Karpati G. Stewart JD, et al. Among authors: mckelvey r. J Neurol Sci. 1996 Oct;142(1-2):59-64. doi: 10.1016/0022-510x(96)00126-8. J Neurol Sci. 1996. PMID: 8902721

2

Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss.

McKelvey R, Bergman H, Stern J, Rush C, Zahirney G, Chertkow H. McKelvey R, et al. Can J Neurol Sci. 1999 Feb;26(1):23-8. Can J Neurol Sci. 1999. PMID: 10068803 Clinical Trial.

3

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, Hartung HP, Arnold D, Kuhle J, Block V, Munschauer FE, Sedel F, Lublin FD; SPI2 investigative teams. Cree BAC, et al. Lancet Neurol. 2020 Dec;19(12):988-997. doi: 10.1016/S1474-4422(20)30347-1. Epub 2020 Oct 23. Lancet Neurol. 2020. PMID: 33222767 Clinical Trial.

4

Editorial: Parent-Based Treatment for Childhood Anxiety.

McKelvey R. McKelvey R. J Am Acad Child Adolesc Psychiatry. 2020 Mar;59(3):342-343. doi: 10.1016/j.jaac.2019.04.025. Epub 2019 May 22. J Am Acad Child Adolesc Psychiatry. 2020. PMID: 31128270

5

Nerve injury and neuropathic pain - A question of age.

Fitzgerald M, McKelvey R. Fitzgerald M, et al. Among authors: mckelvey r. Exp Neurol. 2016 Jan;275 Pt 2:296-302. doi: 10.1016/j.expneurol.2015.07.013. Epub 2015 Jul 26. Exp Neurol. 2016. PMID: 26220898 Free PMC article. Review.

6

Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).

Herrmann N, Harimoto T, Balshaw R, Lanctôt KL; Canadian Outcomes Study in Dementia (COSID) Investigators. Herrmann N, et al. Can J Psychiatry. 2015 Apr;60(4):189-99. doi: 10.1177/070674371506000406. Can J Psychiatry. 2015. PMID: 26174219 Free PMC article.

7

Research on patient safety for off-label use of recombinant factor VIIa.

Aysola AE, Wahi MM, McKelvey RP, Gerdik CR. Aysola AE, et al. Among authors: mckelvey rp. Am J Health Syst Pharm. 2015 Apr 15;72(8):600, 602. doi: 10.2146/ajhp140493. Am J Health Syst Pharm. 2015. PMID: 25825178 No abstract available.

8

Neuropathic pain is constitutively suppressed in early life by anti-inflammatory neuroimmune regulation.

McKelvey R, Berta T, Old E, Ji RR, Fitzgerald M. McKelvey R, et al. J Neurosci. 2015 Jan 14;35(2):457-66. doi: 10.1523/JNEUROSCI.2315-14.2015. J Neurosci. 2015. PMID: 25589741 Free PMC article.

9

The emergence of adolescent onset pain hypersensitivity following neonatal nerve injury.

Vega-Avelaira D, McKelvey R, Hathway G, Fitzgerald M. Vega-Avelaira D, et al. Among authors: mckelvey r. Mol Pain. 2012 Apr 24;8:30. doi: 10.1186/1744-8069-8-30. Mol Pain. 2012. PMID: 22531549 Free PMC article.

10

Evaluation of contraindicated drug-drug interaction alerts in a hospital setting.

Hatton RC, Rosenberg AF, Morris CT, McKelvey RP, Lewis JR. Hatton RC, et al. Among authors: mckelvey rp. Ann Pharmacother. 2011 Mar;45(3):297-308. doi: 10.1345/aph.1P533. Epub 2011 Mar 8. Ann Pharmacother. 2011. PMID: 21386026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results